Susquehanna International Group
CTSO icon

Susquehanna International Group’s Cytosorbents Corp CTSO Stock Holding History

Susquehanna International Group’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-15,100
Closed -$50.9K – 12209
2023
Q1 		$50.9K Buy
+15,100
New +$45.3K ﹤0.01% 11696
2022
Q3 		– Sell
-26,000
Closed -$57K – 13290
2022
Q2 		$57K Buy
26,000
+3,900
+18% +$8.95K ﹤0.01% 11893
2022
Q1 		$70K Buy
+22,100
New +$79.2K ﹤0.01% 12129
2021
Q4 		– Sell
-30,500
Closed -$248K – 13196
2021
Q3 		$248K Buy
30,500
+5,200
+21% +$42.2K ﹤0.01% 11025
2021
Q2 		$191K Sell
25,300
-26,700
-51% -$225K ﹤0.01% 11641
2021
Q1 		$451K Buy
52,000
+18,700
+56% +$178K ﹤0.01% 9713
2020
Q4 		$265K Buy
33,300
+10,600
+47% +$88.7K ﹤0.01% 9529
2020
Q3 		$181K Sell
22,700
-83,600
-79% -$754K ﹤0.01% 9537
2020
Q2 		$1.05M Buy
106,300
+70,300
+195% +$646K ﹤0.01% 5807
2020
Q1 		$278K Buy
+36,000
New +$182K ﹤0.01% 8124
2018
Q4 		– Sell
-27,300
Closed -$352K – 9062
2018
Q3 		$352K Sell
27,300
-17,800
-39% -$223K ﹤0.01% 7156
2018
Q2 		$514K Sell
45,100
-35,500
-44% -$336K ﹤0.01% 6724
2018
Q1 		$568K Buy
80,600
+35,500
+79% +$268K ﹤0.01% 6369
2017
Q4 		$293K Buy
+45,100
New +$287K ﹤0.01% 7632
2017
Q3 		– Sell
-15,300
Closed -$66K – 8912
2017
Q2 		$66K Sell
15,300
-7,700
-33% -$33.8K ﹤0.01% 8830
2017
Q1 		$104K Buy
23,000
+6,800
+42% +$38K ﹤0.01% 8367
2016
Q4 		$88K Sell
16,200
-35,800
-69% -$196K ﹤0.01% 9132
2016
Q3 		$333K Buy
52,000
+21,900
+73% +$114K ﹤0.01% 6760
2016
Q2 		$137K Sell
30,100
-11,400
-27% -$49.6K ﹤0.01% 7866
2016
Q1 		$163K Sell
41,500
-78,900
-66% -$342K ﹤0.01% 8147
2015
Q4 		$671K Buy
120,400
+48,300
+67% +$329K ﹤0.01% 6225
2015
Q3 		$455K Sell
72,100
-12,000
-14% -$80K ﹤0.01% 7302
2015
Q2 		$520K Buy
+84,100
New +$572K ﹤0.01% 7566

Other funds holding CTSO

AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SC
Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Susquehanna International Group's CTSO Position: Q1 2026 in Review

Susquehanna International Group reduced its Cytosorbents Corp (CTSO) stake by 64% in Q1 2026, selling an estimated $36.5K and leaving 29,945 shares worth $17K. The position accounts for ﹤0.01% of the portfolio, ranked #12883.

Susquehanna International Group first reported a position in CTSO in Q1 2015 and has held it in 36 quarters since. The position peaked at $1.11M in Q3 2017. 50 funds tracked by Wall St. Rank hold CTSO as of Q1 2026.

  • Susquehanna International Group held 29,945 shares of Cytosorbents Corp worth $17K as of Q1 2026.
  • Susquehanna International Group sold 53,418 Cytosorbents Corp shares in Q1 2026, an estimated $36.5K.
  • Cytosorbents Corp made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12883 holding.
  • Susquehanna International Group first reported a position in Cytosorbents Corp in Q1 2015 and has held it in 36 quarters since.
  • Susquehanna International Group's Cytosorbents Corp position peaked at $1.11M in Q3 2017.
  • 50 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.